Kehrsatz, Switzerland

Christian Moser

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christian Moser: Innovator in Virosome Technology

Introduction

Christian Moser is a notable inventor based in Kehrsatz, Switzerland. He has made significant contributions to the field of vaccine development, particularly through his innovative work on virosome technology. His research focuses on creating effective vaccines that can combat various viral infections.

Latest Patents

Moser holds a patent for "Virosome particles comprising antigens from influenza virus and hepatitis B virus." This invention provides a virosome that includes a virosomal membrane made up of at least one lipid and envelope proteins from an enveloped virus. The patent also details a vaccine that incorporates this virosome and outlines methods for its production. Furthermore, it describes the use of the virosome in preparing vaccines aimed at preventing or alleviating diseases related to HBV infections.

Career Highlights

Throughout his career, Christian Moser has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Janssen Vaccines AG and Crucell Switzerland AG. His work in these organizations has contributed to advancements in vaccine technology and public health.

Collaborations

Moser has collaborated with several professionals in his field, including Giovanna Assero and Epifanio Fichera. These partnerships have enhanced his research and development efforts, leading to innovative solutions in vaccine production.

Conclusion

Christian Moser's contributions to virosome technology and vaccine development highlight his role as an influential inventor in the biotechnology industry. His work continues to pave the way for advancements in the prevention of viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…